Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Net Cash Flow (2023 - 2025)

Vsee Health (VSEE) has disclosed Net Cash Flow for 3 consecutive years, with $181164.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Cash Flow fell 85.17% year-over-year to $181164.0, compared with a TTM value of -$1.9 million through Sep 2025, down 185.55%, and an annual FY2024 reading of $207381.0, up 285.28% over the prior year.
  • Net Cash Flow was $181164.0 for Q3 2025 at Vsee Health, up from -$118527.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $1.2 million in Q3 2024 and bottomed at -$2.0 million in Q4 2024.
  • Average Net Cash Flow over 3 years is $22253.2, with a median of $84007.0 recorded in 2025.
  • Peak annual rise in Net Cash Flow hit 1316.78% in 2024, while the deepest fall reached 4804.48% in 2024.
  • Year by year, Net Cash Flow stood at -$40804.0 in 2023, then plummeted by 4804.48% to -$2.0 million in 2024, then surged by 109.05% to $181164.0 in 2025.
  • Business Quant data shows Net Cash Flow for VSEE at $181164.0 in Q3 2025, -$118527.0 in Q2 2025, and $84007.0 in Q1 2025.